GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the complex of type II phospholipase A2 with a designed peptide inhibitor phe - leu - ala - tyr - lys at 1.69 a resolution

Analyse Crystal structure of the complex of type II phospholipase A2 with a designed… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4GLD
Type
protein
Length
126 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phospholipase A2 vrv-pl-viiia; Flayk
EC
3.1.1.4
UniProt
D0VX11
Ligands
SO4
Pockets
1 · best druggability 0.26

Structure

x-ray diffraction · 2 distinct chains · 46% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhospholipase A2 vrv-pl-viiia (EC 3.1.1.4)protein12148% helix, 9% strandD0VX11
BFlaykprotein50% helix, 0% strand—

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 2 copies · chains A
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1540.260.7314empty

Interfaces

1 interface between chains.

  • A–B · 542 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 7 disulfide (disulfide).

Compared structures

  • 4GLD · Crystal Structure of the complex of type II phospholipase A2 with a designed peptide… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.